NCT03391869: Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
- State
- Under way
- Phase
- Phase 3
- People
- 339 taking part
- Started
- 29 Dec 2017
- Primary completion
- 31 Mar 2027
- Arms
- Arm A (ipilimumab, nivolumab)
- Results
- None posted
- 29 Dec 2017: Trial started
- 5 Jan 2018: Trial registered